Avidity Partners Management’s ChemoCentryx, Inc. CCXI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-1,175,000
| Closed | -$29.5M | – | 101 |
|
|
2022
Q1 | $29.5M | Buy |
1,175,000
+530,600
| +82% | +$13.3M | 0.61% | 41 |
|
|
2021
Q4 | $23.5M | Buy |
+644,400
| New | +$23.5M | 0.5% | 54 |
|
|
2021
Q2 | – | Sell |
-940,800
| Closed | -$48.2M | – | 143 |
|
|
2021
Q1 | $48.2M | Buy |
940,800
+183,800
| +24% | +$9.42M | 1.33% | 28 |
|
|
2020
Q4 | $46.9M | Buy |
+757,000
| New | +$46.9M | 1.52% | 18 |
|
|
2020
Q3 | – | Sell |
-645,800
| Closed | -$37.2M | – | 95 |
|
|
2020
Q2 | $37.2M | Buy |
645,800
+409,800
| +174% | +$23.6M | 2.38% | 12 |
|
|
2020
Q1 | $9.48M | Buy |
+236,000
| New | +$9.48M | 1.31% | 29 |
|